ICAHRIS
search only ICAHRIS™
Select Language

Management Team

Federico Amezcua
Dr Gabriel Pulido-Cejudo
President and Chairman

Dr Gabriel Pulido-Cejudo

Inventor and author, Dr Gabriel Pulido-Cejudo is President and Chairman at the International Centre for the Advancement of Health Regional Innovation and Science™.
Dr. Carlos Amezcua
Director, BioConvergene Technologies™

Dr Carlos Amezcua

Dr Carlos Amezcua possesses several degrees and academic training from a variety of Universities.
Peter Humphries
Director, iBioSign Health Integrated Systems™

Peter Humphries

Peter Humphries is the Chief Information Officer (CIO) of iBioSign Health Integrated Systems™.
Andrés Pulido Esteva
Chief Filmmaker and Videographer

Andrés Pulido Esteva

As Chief Filmmaker and Videographer at ICAHRIS™, Andrés is responsible for our promotional and documentary videos.
Dr Khadija El Abdaimi, PhD
Advisory Board Member

Dr Khadija El Abdaimi, PhD

A scientist with extensive experience in research and development, both in academic as well as within the Life Sciences and related industry sectors.
Mary Stier-Meyer
Advisory Board Member

Mary Stier-Meyer

Mary, a successful and vibrant entrepreneur, has joined the advisory board of ICAHRIS™.
Sara Ravelo
Advisory Board Member

Sara Ravelo

Sara, a young, prominent musician, has joined the advisory board of ICAHRIS™.
Oksana Pavlova
Advisory Board Member

Oksana Pavlova

Oksana, a vibrant Ukrainian pianist, has joined the advisory board of ICAHRIS™.
Mónica Muraira
Advisory Board Member

Mónica Muraira

Mónica, a successful media host, has joined the advisory board of ICAHRIS™.
Richard A. Patten
Former Director, BioConvergene Technologies™

Richard A. Patten

Richard A. Patten had a vast experience in the voluntary and private Sectors.

Federico Amezcua

Executive Summary

Federico Amezcua commenced his professional career as an accomplished lawyer focused on the regional growth of Sahuayo, a prosperous town located within the State of Michoacan in the Western Pacific Coast of Mexico. Taking advantage of the proximity of Sahuayo to Guadalajara, the Capital City of the State of Jalisco, the third most robust State of Mexico, as a young entrepreneur he envisaged harnessing a culture of highly trained professionals interested in creating a biopharmaceutical hub in his family home town.

In less than a decade, he succeeded in manufacturing and commercializing more than fifty pharmaceuticals and specialized products including immunosuppressants, anti-inflammatory agents, antibiotics, anti-hypertensive drugs, migraine blockers amongst several other compounds, enabling Sahuayo to become a pharmaceutical hub.

As an executive of the Board of Directors, Federico Amezcua, Dr Carlos Amezcua and Dr Gabriel Pulido-Cejudo co-founded BioConverGene Technologies Corporation™ to design, manufacture and commercialize various biopharmaceutical and specialized biomolecules for the prevention and treatment of inflammation, cancer, and obesity as well as the tailoring of vaccines and anti-toxins, recombinant stabilizing peptides and growth factors, stem cells and synthetic blood products.

Federico Amezcua is an active member of the Chamber of Commerce of Sahuayo as well as of CANIFARMA, a Federal Association of the Pharmaceutical Industry.